{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:25:44Z","timestamp":1789431944135,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biomed Sci"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Influenza viruses are a major cause of morbidity and mortality around the world. More recently, a swine-origin influenza A (H1N1) virus that is spreading via human-to-human transmission has become a serious public concern. Although vaccination is the primary strategy for preventing infections, influenza antiviral drugs play an important role in a comprehensive approach to controlling illness and transmission. In addition, a search for influenza-inhibiting drugs is particularly important in the face of high rate of emergence of influenza strains resistant to several existing influenza antivirals.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We searched for novel anti-influenza inhibitors using a cell-based neutralization (inhibition of virus-induced cytopathic effect) assay. After screening 20,800 randomly selected compounds from a library from ChemDiv, Inc., we found that BPR1P0034 has sub-micromolar antiviral activity. The compound was resynthesized in five steps by conventional chemical techniques. Lead optimization and a structure-activity analysis were used to improve potency. Time-of-addition assay was performed to target an event in the virus life cycle.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The 50% effective inhibitory concentration (IC<jats:sub>50<\/jats:sub>) of BPR1P0034 was 0.42 \u00b1 0.11 \u03bcM, when measured with a plaque reduction assay. Viral protein and RNA synthesis of A\/WSN\/33 (H1N1) was inhibited by BPR1P0034 and the virus-induced cytopathic effects were thus significantly reduced. BPR1P0034 exhibited broad inhibition spectrum for influenza viruses but showed no antiviral effect for enteroviruses and echovirus 9. In a time-of-addition assay, in which the compound was added at different stages along the viral replication cycle (such as at adsorption or after adsorption), its antiviral activity was more efficient in cells treated with the test compound between 0 and 2 h, right after viral infection, implying that an early step of viral replication might be the target of the compound. These results suggest that BPR1P0034 targets the virus during viral uncoating or viral RNA importation into the nucleus.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>To the best of our knowledge, BPR1P0034 is the first pyrazole-based anti-influenza compound ever identified and characterized from high throughput screening to show potent (sub-\u03bcM) antiviral activity. We conclude that BPR1P0034 has potential antiviral activity, which offers an opportunity for the development of a new anti-influenza virus agent.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1423-0127-17-13","type":"journal-article","created":{"date-parts":[[2010,2,23]],"date-time":"2010-02-23T19:15:41Z","timestamp":1266952541000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":90,"title":["Pyrazole compound BPR1P0034 with potent and selective anti-influenza virus activity"],"prefix":"10.1186","volume":"17","author":[{"given":"Shin-Ru","family":"Shih","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Yun","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gadarla Randheer","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Nain","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiun-Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Fang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-sian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiann-Yih","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Sheng","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John TA","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsing-Pang","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim-Tong","family":"Horng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,2,23]]},"reference":[{"issue":"34","key":"127_CR1","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.2174\/138161207782794248","volume":"13","author":"HP Hsieh","year":"2007","unstructured":"Hsieh HP, Hsu JT: Strategies of development of antiviral agents directed against influenza virus replication. Current pharmaceutical design. 2007, 13 (34): 3531-3542. 10.2174\/138161207782794248.","journal-title":"Current pharmaceutical design"},{"key":"127_CR2","first-page":"1487","volume-title":"Fields Virology","author":"R Lamb","year":"2001","unstructured":"Lamb R, Krug RM: Orthomyxoviridae: The viruses and their replication. Fields Virology. Edited by: Knipe DM, Howley PM. 2001, Linpicott Williams & Wilkins, Philadelphia, PA, USA, 1487-1531. 4","edition":"4"},{"issue":"8","key":"127_CR3","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1001\/jama.295.8.joc60020","volume":"295","author":"RA Bright","year":"2006","unstructured":"Bright RA, Shay DK, Shu B, Cox NJ, Klimov AI: Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. Jama. 2006, 295 (8): 891-894. 10.1001\/jama.295.8.joc60020.","journal-title":"Jama"},{"issue":"2","key":"127_CR4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1086\/518936","volume":"196","author":"VM Deyde","year":"2007","unstructured":"Deyde VM, Xu X, Bright RA, Shaw M, Smith CB, Zhang Y, Shu Y, Gubareva LV, Cox NJ, Klimov AI: Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide. The Journal of infectious diseases. 2007, 196 (2): 249-257. 10.1086\/518936.","journal-title":"The Journal of infectious diseases"},{"issue":"1","key":"127_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jcv.2007.10.020","volume":"41","author":"O Ferraris","year":"2008","unstructured":"Ferraris O, Lina B: Mutations of neuraminidase implicated in neuraminidase inhibitors resistance. J Clin Virol. 2008, 41 (1): 13-19. 10.1016\/j.jcv.2007.10.020.","journal-title":"J Clin Virol"},{"issue":"2","key":"127_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3201\/eid1502.081031","volume":"15","author":"SH Hauge","year":"2009","unstructured":"Hauge SH, Dudman S, Borgen K, Lackenby A, Hungnes O: Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08. Emerging infectious diseases. 2009, 15 (2): 155-162. 10.3201\/eid1502.081031.","journal-title":"Emerging infectious diseases"},{"issue":"4","key":"127_CR7","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3201\/eid1504.181280","volume":"15","author":"A Meijer","year":"2009","unstructured":"Meijer A, Lackenby A, Hungnes O, Lina B, van-der-Werf S, Schweiger B, Opp M, Paget J, van-de-Kassteele J, Hay A, Zambon M: Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season. Emerging infectious diseases. 2009, 15 (4): 552-560. 10.3201\/eid1504.081280.","journal-title":"Emerging infectious diseases"},{"issue":"25","key":"127_CR8","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1056\/NEJMoa054512","volume":"353","author":"MD de Jong","year":"2005","unstructured":"de Jong MD, Tran TT, Truong HK, Vo MH, Smith GJ, Nguyen VC, Bach VC, Phan TQ, Do QH, Guan Y, Peiris JS, Tran TH, Farrar J: Oseltamivir resistance during treatment of influenza A (H5N1) infection. The New England journal of medicine. 2005, 353 (25): 2667-2672. 10.1056\/NEJMoa054512.","journal-title":"The New England journal of medicine"},{"issue":"7062","key":"127_CR9","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/4371108a","volume":"437","author":"QM Le","year":"2005","unstructured":"Le QM, Kiso M, Someya K, Sakai YT, Nguyen TH, Nguyen KH, Pham ND, Ngyen HH, Yamada S, Muramoto Y, Horimoto T, Takada A, Goto H, Suzuki T, Suzuki Y, Kawaoka Y: Avian flu: isolation of drug-resistant H5N1 virus. Nature. 2005, 437 (7062): 1108-10.1038\/4371108a.","journal-title":"Nature"},{"issue":"8","key":"127_CR10","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1177\/135965350501000811","volume":"10","author":"F Hayden","year":"2005","unstructured":"Hayden F, Klimov A, Tashiro M, Hay A, Monto A, McKimm-Breschkin J, Macken C, Hampson A, Webster RG, Amyard M, Zambon M: Neuraminidase inhibitor susceptibility network position statement: antiviral resistance in influenza A\/H5N1 viruses. Antiviral therapy. 2005, 10 (8): 873-877.","journal-title":"Antiviral therapy"},{"key":"127_CR11","doi-asserted-by":"crossref","unstructured":"Outbreak of swine-origin influenza A (H1N1) virus infection - Mexico, March-April 2009. Mmwr. 2009, 58 (17): 467-470.","DOI":"10.1016\/S0084-3873(09)79323-X"},{"key":"127_CR12","unstructured":"Swine-origin influenza A (H1N1) virus infections in a school - New York City, April 2009. Mmwr. 2009, 58 (17): 470-472."},{"key":"127_CR13","unstructured":"Update: infections with a swine-origin influenza A (H1N1) virus--United States and other countries, April 28, 2009. Mmwr. 2009, 58 (16): 431-433."},{"issue":"25","key":"127_CR14","first-page":"2605","volume":"360","author":"FS Dawood","year":"2615","unstructured":"Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, Gubareva LV, Xu X, Bridges CB, Uyeki TM: Emergence of a novel swine-origin influenza A (H1N1) virus in humans. The New England journal of medicine. 2615, 360 (25): 2605-2009.","journal-title":"The New England journal of medicine"},{"issue":"3","key":"127_CR15","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.antiviral.2005.06.006","volume":"67","author":"M Westby","year":"2005","unstructured":"Westby M, Nakayama GR, Butler SL, Blair WS: Cell-based and biochemical screening approaches for the discovery of novel HIV-1 inhibitors. Antiviral Res. 2005, 67 (3): 121-140. 10.1016\/j.antiviral.2005.06.006.","journal-title":"Antiviral Res"},{"issue":"1","key":"127_CR16","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.antiviral.2006.07.006","volume":"73","author":"JW Noah","year":"2007","unstructured":"Noah JW, Severson W, Noah DL, Rasmussen L, White EL, Jonsson CB: A cell-based luminescence assay is effective for high-throughput screening of potential influenza antivirals. Antiviral Res. 2007, 73 (1): 50-59. 10.1016\/j.antiviral.2006.07.006.","journal-title":"Antiviral Res"},{"issue":"6","key":"127_CR17","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1177\/1087057105276474","volume":"10","author":"ME Digan","year":"2005","unstructured":"Digan ME, Pou C, Niu H, Zhang JH: Evaluation of division-arrested cells for cell-based high-throughput screening and profiling. J Biomol Screen. 2005, 10 (6): 615-623. 10.1177\/1087057105276474.","journal-title":"J Biomol Screen"},{"issue":"6","key":"127_CR18","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1128\/jvi.70.6.4188-4192.1996","volume":"70","author":"S Pleschka","year":"1996","unstructured":"Pleschka S, Jaskunas R, Engelhardt OG, Zurcher T, Palese P, Garcia-Sastre A: A plasmid-based reverse genetics system for influenza A virus. Journal of virology. 1996, 70 (6): 4188-4192.","journal-title":"Journal of virology"},{"issue":"2","key":"127_CR19","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.antiviral.2008.10.006","volume":"81","author":"HC Hung","year":"2009","unstructured":"Hung HC, Tseng CP, Yang JM, Ju YW, Tseng SN, Chen YF, Chao YS, Hsieh HP, Shih SR, Hsu JT: Aurintricarboxylic acid inhibits influenza virus neuraminidase. Antiviral Res. 2009, 81 (2): 123-131. 10.1016\/j.antiviral.2008.10.006.","journal-title":"Antiviral Res"},{"issue":"2","key":"127_CR20","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0003-2697(79)90362-2","volume":"94","author":"M Potier","year":"1979","unstructured":"Potier M, Mameli L, Belisle M, Dallaire L, Melancon SB: Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate. Analytical biochemistry. 1979, 94 (2): 287-296. 10.1016\/0003-2697(79)90362-2.","journal-title":"Analytical biochemistry"},{"issue":"16","key":"127_CR21","doi-asserted-by":"publisher","first-page":"4521","DOI":"10.1016\/j.bmcl.2008.07.047","volume":"18","author":"LF Zeng","year":"2008","unstructured":"Zeng LF, Zhang HS, Wang YH, Sanchez T, Zheng YT, Neamati N, Long YQ: Efficient synthesis and utilization of phenyl-substituted heteroaromatic carboxylic acids as aryl diketo acid isosteres in the design of novel HIV-1 integrase inhibitors. Bioorganic & medicinal chemistry letters. 2008, 18 (16): 4521-4524. 10.1016\/j.bmcl.2008.07.047.","journal-title":"Bioorganic & medicinal chemistry letters"},{"issue":"6","key":"127_CR22","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1021\/jm051229y","volume":"49","author":"JR Goodell","year":"2137","unstructured":"Goodell JR, Puig-Basagoiti F, Forshey BM, Shi PY, Ferguson DM: Identification of compounds with anti-West Nile Virus activity. Journal of medicinal chemistry. 2137, 49 (6): 2127-2006. 10.1021\/jm051229y.","journal-title":"Journal of medicinal chemistry"},{"issue":"8","key":"127_CR23","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1016\/j.ejmech.2009.02.012","volume":"44","author":"AE Rashad","year":"2009","unstructured":"Rashad AE, Hegab MI, Abdel-Megeid RE, Fathalla N, Abdel-Megeid FM: Synthesis and anti-HSV-1 evaluation of some pyrazoles and fused pyrazolopyrimidines. European journal of medicinal chemistry. 2009, 44 (8): 3285-3292. 10.1016\/j.ejmech.2009.02.012.","journal-title":"European journal of medicinal chemistry"},{"issue":"5","key":"127_CR24","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/ardp.200700005","volume":"340","author":"AH Shamroukh","year":"2007","unstructured":"Shamroukh AH, Zaki ME, Morsy EM, Abdel-Motti FM, Abdel-Megeid FM: Synthesis of pyrazolo[4',3':5,6]pyrano [2,3-d]pyrimidine derivatives for antiviral evaluation. Archiv der Pharmazie. 2007, 340 (5): 236-243. 10.1002\/ardp.200700005.","journal-title":"Archiv der Pharmazie"},{"issue":"2","key":"127_CR25","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S1471-4914(02)00010-2","volume":"9","author":"S Ludwig","year":"2003","unstructured":"Ludwig S, Planz O, Pleschka S, Wolff T: Influenza-virus-induced signaling cascades: targets for antiviral therapy?. Trends in molecular medicine. 2003, 9 (2): 46-52. 10.1016\/S1471-4914(02)00010-2.","journal-title":"Trends in molecular medicine"},{"issue":"4","key":"127_CR26","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1086\/505868","volume":"43","author":"N Kawai","year":"2006","unstructured":"Kawai N, Ikematsu H, Iwaki N, Maeda T, Satoh I, Hirotsu N, Kashiwagi S: A comparison of the effectiveness of oseltamivir for the treatment of influenza A and influenza B: a Japanese multicenter study of the 2003-2004 and 2004-2005 influenza seasons. Clin Infect Dis. 2006, 43 (4): 439-444. 10.1086\/505868.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"127_CR27","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1086\/429241","volume":"40","author":"N Kawai","year":"2005","unstructured":"Kawai N, Ikematsu H, Iwaki N, Satoh I, Kawashima T, Maeda T, Miyachi K, Hirotsu N, Shigematsu T, Kashiwagi S: Factors influencing the effectiveness of oseltamivir and amantadine for the treatment of influenza: a multicenter study from Japan of the 2002-2003 influenza season. Clin Infect Dis. 2005, 40 (9): 1309-1316. 10.1086\/429241.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"127_CR28","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1086\/509925","volume":"44","author":"N Sugaya","year":"2007","unstructured":"Sugaya N, Mitamura K, Yamazaki M, Tamura D, Ichikawa M, Kimura K, Kawakami C, Kiso M, Ito M, Hatakeyama S, Kawaoka Y: Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children. Clin Infect Dis. 2007, 44 (2): 197-202. 10.1086\/509925.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"127_CR29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.antiviral.2008.10.006","volume":"81","author":"HC Hung","year":"2009","unstructured":"Hung HC, Tseng CP, Yang JM, Ju YW, Tseng SN, Chen YF, Chao YS, Hsieh HP, Shih SR, Hsu JT: Aurintricarboxylic acid inhibits influenza virus neuraminidase. Antiviral Res. 2009, 81 (2): 123-131. 10.1016\/j.antiviral.2008.10.006.","journal-title":"Antiviral Res"},{"key":"127_CR30","doi-asserted-by":"crossref","unstructured":"Shih SR, Horng JT, Poon LL, Chen TC, Yeh JY, Hsieh HP, Tseng SN, Chiang C, Li WL, Chao YS, Hsu JT: BPR2-D2 targeting viral ribonucleoprotein complex-associated function inhibits oseltamivir-resistant influenza viruses. The Journal of antimicrobial chemotherapy. 65 (1): 63-71. 10.1093\/jac\/dkp393.","DOI":"10.1093\/jac\/dkp393"},{"issue":"7","key":"127_CR31","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.cell.2009.12.017","volume":"139","author":"AL Brass","year":"2009","unstructured":"Brass AL, Huang IC, Benita Y, John SP, Krishnan MN, Feeley EM, Ryan BJ, Weyer JL, Weyden van der L, Fikrig E, Adams DJ, Xavier RJ, Farzan M, Elledge SJ: The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell. 2009, 139 (7): 1243-1254. 10.1016\/j.cell.2009.12.017.","journal-title":"Cell"},{"key":"127_CR32","volume-title":"Nature","author":"R Konig","year":"2009","unstructured":"Konig R, Stertz S, Zhou Y, Inoue A, Heinrich Hoffmann H, Bhattacharyya S, Alamares JG, Tscherne DM, Ortigoza MB, Liang Y, Gao Q, Andrews SE, Bandyopadhyay S, De Jesus P, Tu BP, Pache L, Shih C, Orth A, Bonamy G, Miraglia L, Ideker T, Garcia-Sastre A, Young JA, Palese P, Shaw ML, Chanda SK: Human host factors required for influenza virus replication. Nature. 2009,"},{"issue":"7","key":"127_CR33","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.cell.2009.12.018","volume":"139","author":"SD Shapira","year":"2009","unstructured":"Shapira SD, Gat-Viks I, Shum BO, Dricot A, de Grace MM, Wu L, Gupta PB, Hao T, Silver SJ, Root DE, Hill DE, Regev A, Hacohen N: A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell. 2009, 139 (7): 1255-1267. 10.1016\/j.cell.2009.12.018.","journal-title":"Cell"}],"container-title":["Journal of Biomedical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1423-0127-17-13.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T15:06:13Z","timestamp":1685459173000},"score":1,"resource":{"primary":{"URL":"https:\/\/jbiomedsci.biomedcentral.com\/articles\/10.1186\/1423-0127-17-13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,23]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["127"],"URL":"https:\/\/doi.org\/10.1186\/1423-0127-17-13","relation":{},"ISSN":["1423-0127"],"issn-type":[{"value":"1423-0127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,23]]},"assertion":[{"value":"13 August 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"13"}}